GHK-Cu is a synthetic copper-binding tripeptide studied in research into extracellular-matrix remodelling, copper transport and tissue-repair pathways in experimental models.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, also known as copper tripeptide-1 or prezatide copper. It has the molecular formula C14H23CuN6O4+, a molecular weight of 402.92 g/mol, CAS 89030-95-5 and PubChem CID 71587328. Kyrolabs supplies it as a research reference material only.
GHK-Cu is not a controlled drug under the Misuse of Drugs Act 1971 and is not scheduled in the UK. It is supplied for laboratory research use only, holds no marketing authorisation, and cannot be sold or supplied for human consumption or any in-vivo use. The purchaser is responsible for lawful handling.
Published work references GHK-Cu in the context of collagen, extracellular-matrix remodelling, copper-dependent cellular processes and gene-expression profiling. These describe laboratory and pre-clinical research questions, not established outcomes. None of it demonstrates a benefit or effect in humans. The detailed evidence audit is in our blog monograph.
No. GHK-Cu is supplied as a research chemical for laboratory use only and is not for human consumption. It is not a cosmetic, supplement or medicine, so it must not be ingested, injected, applied to skin, or used in any in-vivo way. Any handling is confined to a controlled research setting.
Kyrolabs offers no guidance on combining research compounds in any living system, because none of these materials is for human or animal use. GHK-Cu and BPC-157 are sold separately as laboratory reference materials only; any handling is a research procedure, not a protocol for in-vivo use.
No. Quality and identity vary by source. Confirm the material against its verified identifiers (CAS 89030-95-5, CID 71587328, formula C14H23CuN6O4+, MW 402.92 g/mol) and demand a batch-specific Certificate of Analysis. Kyrolabs assays every lot to a minimum 99% HPLC purity and publishes the CoA.
GHK-Cu is a specific copper peptide: the copper(II) complex of the Gly-His-Lys tripeptide, catalogued as copper tripeptide-1. The term copper peptide is a broader category that includes other peptide-copper complexes, so GHK-Cu is one defined member of that group rather than a synonym for it.
GHK-Cu has the molecular formula C14H23CuN6O4+ and a molecular weight of 402.92 g/mol. Its sequence is glycyl-L-histidyl-L-lysine (Gly-His-Lys) as a copper complex, with CAS 89030-95-5 and PubChem CID 71587328.
No. GHK-Cu is supplied by Kyrolabs as a research reference material for laboratory use only. It is not a cosmetic, supplement or medicine and is not for human consumption, ingestion, topical application or any in-vivo application.
GHK-Cu is supplied as a lyophilised powder and can be reconstituted for laboratory use with a suitable solvent such as bacteriostatic water. The copper coordination gives the reconstituted material a characteristic blue colour. Reconstitution is a laboratory handling step only and does not imply any in-vivo use.
Lyophilised GHK-Cu is typically stored cold and protected from light and moisture; once reconstituted, research peptides are generally kept refrigerated. Refer to the documentation accompanying your batch for the storage guidance specific to that lot.
Yes. Every batch is released with a batch-specific Certificate of Analysis showing chromatographic purity and identity, assayed to a minimum 99% by HPLC. Current certificates are published on the Kyrolabs CoA page so the identifiers can be verified against the documentation.
No. GHK-Cu holds no UK marketing authorisation, so it is not a licensed prescription product. Kyrolabs supplies it only as a research chemical for laboratory use and makes no claim about any clinical pathway.
No. Kyrolabs supplies GHK-Cu as a lyophilised research powder, not as a cosmetic serum, cream or skincare formulation. It is a laboratory reference material for research use only, with no cosmetic, topical or in-vivo application. It is not a licensed medicine and holds no marketing authorisation. Researchers reconstitute the powder with a suitable solvent such as bacteriostatic water for bench work only.
No human safety profile has been established. GHK-Cu has not been evaluated by any regulator as a medicine, holds no marketing authorisation, and is supplied strictly as a research chemical for laboratory use, not for human consumption or any in-vivo use. The published literature describes pre-clinical and in-vitro research questions only and does not establish a safety or effect profile in humans.
Related
There are no reviews yet. Be the first to leave one.
KYRO supplies research-grade peptides for laboratory and in-vitro studies only. They are not medicines, hold no UK marketing authorisation, and are not presented to diagnose, treat, cure, prevent, or mitigate any condition. We do not provide therapeutic, dosing, or medical advice. By placing an order you confirm you are 18+ and acting as a qualified person in a research capacity.
Independent UK supplier of high-purity research peptides. Every batch HPLC-tested, cold-chain stored, and dispatched same-day from our Greater London facility.
© 2026 Kyrolabs Group Ltd.
